Victrex plc (LON:VCT) Stock Has Consensus Price Target of GBX 807.86 According to Analysts

Victrex plc (LON:VCT) has earned a consensus rating of “Hold” from the seven brokerages that are presently covering the company, MarketBeat reports. One investment analyst has rated the stock with a sell recommendation, five have given a hold recommendation and one has given a buy recommendation to the company. The average 1-year price objective among analysts that have updated their coverage on the stock in the last year is GBX 807.86.

A number of research analysts recently commented on the stock. Citigroup increased their price target on shares of Victrex from GBX 700 to GBX 1,000 and gave the company a “neutral” rating in a report on Friday, September 11th. Canaccord Genuity Group lifted their target price on Victrex from GBX 725 to GBX 1,050 and gave the stock a “buy” rating in a report on Tuesday, September 29th. JPMorgan Chase & Co. increased their price target on Victrex from GBX 625 to GBX 785 and gave the company a “neutral” rating in a report on Thursday, September 10th. Berenberg Bank raised their price target on Victrex from GBX 680 to GBX 870 and gave the stock a “hold” rating in a research report on Friday, September 11th. Finally, Jefferies Financial Group reaffirmed a “hold” rating and set a GBX 595 price objective on shares of Victrex in a research note on Friday, September 25th.

Victrex Price Performance

VCT opened at GBX 942 on Thursday. The company’s 50-day simple moving average is GBX 880.96 and its two-hundred day simple moving average is GBX 717.96. Victrex has a 52-week low of GBX 515 and a 52-week high of GBX 1,024. The stock has a market capitalization of £821.01 million, a P/E ratio of -42.05, a P/E/G ratio of 1.92 and a beta of 0.82. The company has a debt-to-equity ratio of 21.30, a quick ratio of 1.99 and a current ratio of 2.35.

About Victrex

Victrex plc, through its subsidiaries, engages in the manufacture and sale of polymer solutions worldwide. The company operates through two segments, Sustainable Solutions and Medical. It develops PEEK and PAEK based polymer solutions, and semi-finished and finished parts. The company also provides specialist solutions for medical device manufacturers; sells thermoplastic polymers; sustainable solutions for energy and industrial, VAR, automotive, aerospace, and electronics markets; and engages in trading activities.